Pharmafile Logo

The Center for Professional Innovation & Education

From product development through commercialization, CfPIE has the pharmaceutical training, biotechnology training and medical device training solutions to help you advance your career and keep your firm compliant. At CfPIE, we’re in the business of making employees more valuable and keeping your firm compliant with industry regulations. Register for a biopharmaceutical, medical device, biotech or pharmaceutical training course today. CfPIE provides “results that matter, programs that work and solutions that last.”

This is a FREE LISTING on PMHUB

Below are full profiles from other companies in related areas

Amiculum

AMICULUM works with the global healthcare industry to bring science to life across the product lifecycle from early opportunity assessment through to launch and beyond. By listening to the changing…

View Profile

Dice Medical Communications

Dice Medical Communications is an independent communications agency that works with our clients to help launch, build, and continually develop great pharmaceutical brands. We do this by creating Pharmacohesion™.

View Profile

Impetus Digital

Impetus Digital has offered virtual advisory boards, clinical trial investigator consortiums, co-author publication working groups, steering committees, and medical education to life science companies from around the globe since 2008.

View Profile

M3 (EU)

M3 has over 20 years’ experience in building online doctor communities. M3 is the world’s largest network of verified doctors with over 6 million members across M3-owned networks and an…

View Profile

OPEN Health

OPEN Health brings together deep scientific knowledge, global understanding, and broad specialist expertise to support our clients in improving health outcomes and patient wellbeing.

View Profile

Company Details

7 Great Valley Parkway, Suite 128, Malvern, PA, 19355, United States
+1-610-688-1708

 Latest Content from PMHub 

Beyond the patient journey: Designing for behaviour change

In 2016, it’s time to update our model for the customer journey. Customer Experience Consultant Anna Tamasi talks us through the future of journey mapping.

Should We Care About Rare Diseases? By Alastair Kent

Alastair Kent, OBE, the Director of Genetic Alliance UK and chair of Rare Disease UK tells us why it’s so important to care about rare disease and why we should...

Breaking Down the Barriers to Behaviour Change by Patrick Ladbury

Patrick Ladbury, the Director at the NSMC delves further into the barriers to behaviour change, and offers us tricks of the trade in his second instalment.

Affiliate friendly content: e-detailing materials that local markets love

What’s the point of marketing content that doesn’t get used?

Brand teams: They’re not what you think they are

Head of Commercial Matt Bolton of Blue Latitude Health breaks down what we mean when we talk about eliminating the last silos in pharma marketing.

Blue Latitude Health to sponsor and co-present in the Innovation Track at ProcureCon Healthcare 2016

Press Releases | February 19, 2016 | Blue Latitude Health

Blue Latitude Health’s Managing Director, Martin Brass, and Johnson & Johnson’s Director, David McKimm, to co-present on the topic “Optimising Your Marketing Spend in New Ways to Create Value for...

Why are doctors frustrated with the digitalisation of healthcare?

In this article, Customer Experience Consultant Anna Tamasi from Blue Latitude Health highlights the most common usability and user experience implications that the digitalisation of healthcare poses on doctors professional...

Changing faces – overcoming the taboo of marketing to a mature audience

Our new blog highlights the challenges for communicating to consumers who are 50+ and how they must be tackled in order to create marketing opportunities.

It’s time to get with the real world

Lucid CEO discusses the increasing importance placed on real-world data to demonstrate value

Free Thinking: From promise to practice: immuno-oncology in action

White Papers and Resources | February 9, 2016 | Inizio

Our latest Free Thinking white paper series explores what the global outlook is like for new immunotherapy products and asks key opinion leaders and payers how they’re faring both clinically...